BioSpace News Archive

Enhancements in wages and nurse-staffing levels expected to improve nurse recruitment and retention, as well as the quality of patient care

Vast Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, announced that another of its drug candidates, BIOC11, has been designated as a “Qualified Infectious Disease Product” by the U.S. Food and Drug Administration.

Medical Marijuana, Inc. announced that its subsidiary Kannaway® has earned two prestigious Golden Bridge Awards® -- including a Silver Award for Company of the Year in the Healthcare Products and Services category and the Company’s CEO Blake Schroeder earned a Gold Award for International Executive of the Year in the Healthcare Products and Services category.

New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, announced the majority recapitalization of the company by Ampersand Capital Partners.

SAB Members Bring Cancer Immunotherapy and Clinical Trial Experience to the Development of Bolt’s Immune-stimulating Antibody Conjugate Technology

Leveraging leading supply chain optimization and simulation technology to maximize the impact of nonprofit’s mission to restore sight and prevent blindness

He will oversee the company’s product, delivery and support functions.

Partnership Combines Life Image’s Global Medical Evidence Network Specializing in Imaging Data with Graticule’s Deep Expertise Applying Advanced Data to High-Value Use Cases

Automated Digital Patient Management Increases Care Quality, Staff Efficiency and Revenue

Unisys Corporation (NYSE: UIS) today announced that the U.S. Department of Health and Human Services (HHS) has selected the company to compete for task and delivery orders under the Intelligent Automation/Artificial Intelligence (IAAI) contract.